Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/cell.2021.29046.kk | DOI Listing |
Cell Reprogram
December 2024
CNC - Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Cell Reprogram
December 2024
CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Int J Mol Sci
November 2024
Institute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland.
Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterized by disruptions in the dystrophin gene. This study aims to investigate potential a therapeutic approach using genetically modified human iPS-derived mesoangioblast-like cells (HIDEMs) in mouse model. This study utilizes patient-specific myoblasts reprogrammed to human induced pluripotent stem cells (iPSCs) and then differentiated into HIDEMs.
View Article and Find Full Text PDFCell Reprogram
October 2024
CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
mBio
November 2024
Department of Biological Sciences, Indian Institute of Science Education and Research, Mohali, Punjab, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!